Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Daniel McAleese

Pharmacovigilance Administrator

Following completion of a MSc in Public Health, I joined the Oncology Clinical Trials Office (OCTO) in December 2017 as a Clinical Trial Support Officer. After spending a year at an international CRO in 2019 gaining experience on industry-led research, I returned to OCTO as Pharmacovigilance Administrator. Among others, a primary responsibility of the Pharmacovigilance Team is to process all Serious Adverse Events submitted from participating hospitals across all safety reporting CTIMPs and Device Clinical Trials conducted out of OCTO, checking the cases for completeness, accuracy and medical sense.